Drug Price Reference Index 2020 ?? DOH
Drug Price Reference Index 2020 ?? DOH
(GIDA Area)
A
1. Acetazolamide 250 mg Tablet 20.00 - 20.00 20.00
2. Acetylcysteine 200 mg/mL, 25 mL 982.00 - 1,813.00 1,500.00
Bottle
3. Aciclovir 400 mg Tablet 6.50 - 30.50 17.88
4. All-in-One Admixtures ("3-in-1" or 2,800.00 - 3,500.00 2,800.00
"dual energy" solutions) "3 in 1" 1500
Kcal Bottle
5. Alprazolam 500 mcg Tablet 7.90 - 19.00 7.90
6. Aluminum Hydroxide + Magnesium 0.49 - 1.90 1.50
Hydroxide 200 mg + 100 mg Tablet
7. Aluminum Hydroxide + Magnesium 27.80 - 40.00 39.00
Hydroxide 225 mg + 200 mg/5 mL,
120 mL Suspension
8. Amoxicillin 100 mg/mL, 15 mL Drops 13.10 - 38.45 18.85
9. Amoxicillin 250 mg Capsule 1.01 - 2.31 1.25
10. Ascorbic Acid (Vitamin C) 100 13.50 - 50.00 17.10
mg/ml, 15 mL Oral Drops
11. Ascorbic Acid (Vitamin C) 100 50.00 - 50.00 50.00
mg/ml, 30 mL Oral Drops
12. Atenolol 100 mg Tablet 2.81 - 3.20 2.81
13. Atorvastatin 10 mg Tablet 2.08 - 11.54 5.00
14. Atorvastatin 40 mg Tablet 3.10 - 19.33 9.88
15. Azathioprine 50 mg tablet - 38.42
B
16. Baclofen 10 mg Tablet 10.70 - 18.00 15.25
17. Basiliximab 20 mg vial - 43,495.83
18. Beractant 25 mg/mL, 8 mL Vial - 15,776.53
19. Bicalutamide 50 mg Tablet 48.50 - 80.00 48.50
20. Biperiden Hydrochloride 2 mg Tablet 4.00 - 10.40 5.22
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
22. Butamirate Citrate 7.5 mg/5 mL, 120 120.00 - 170.00 120.00
mL Syrup
C
23. Calcium Carbonate + Cholecalciferol 2.20 - 6.00 3.65
(Vit. D3) 600 mg elementa Ca + 400
IU Vit. D3 Tablet
24. Calcium Gluconate 10%, 20 mL 48.00 - 50.00 48.00
Bottle
25. Carbetocin 100 mcg/mL, 1 mL Vial - 933.00
26. Carboprost 250 mcg/mL Solution 195.00 - 560.70 283.50
27. Carvedilol 25 mg Tablet 3.40 - 7.50 4.45
28. Cefalexin 100 mg/mL, 10 mL Drops 16.00 - 28.10 20.54
29. Cefalexin 250 mg/5 mL, 60 mL Bottle 20.00 - 65.00 26.25
30. Cefepime 2 g Vial 218.22 - 1,618.00 418.00
31. Ceftazidime 500 mg Vial 64.93 - 620.00 64.93
32. Cefuroxime 250 mg/5 mL, 120 mL 151.00 - 165.00 151.00
Granule for suspension
33. Celecoxib 200 mg Capsule 1.30 - 19.00 3.25
34. Cetirizine (as Dihydrochloride) 2.5 22.10 - 140.00 35.88
mg/mL, 10mL Syrup
35. Cetirizine (as Dihydrochloride) 5 60.00 - 100.00 70.00
mg/5 mL, 30 mL Syrup
36. Cetirizine 1 mg/mL, 30 mL Bottle 29.00 - 113.85 65.00
37. Cetirizine 1 mg/mL, 60 mL Bottle 19.50 - 245.00 55.00
38. Cetirizine 10 mg Tablet 0.27 - 15.00 0.43
39. Chloramphenicol 1 g Vial 24.33 - 49.88 38.98
The Reference Price was based on the proposed list price of the pharmaceutical company upon its inclusion in the Philippine
National Formulary (PNF) (excluded from the maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the proposed list price of the pharmaceutical company upon its inclusion in the Philippine
National Formulary (PNF) (excluded from the maximum 10% inflationary cost)
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the proposed list price of the pharmaceutical company upon its inclusion in the Philippine
National Formulary (PNF) (excluded from the maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation
The Reference Price was based on the proposed list price of the pharmaceutical company upon its inclusion in the Philippine
National Formulary (PNF) (excluded from the maximum 10% inflationary cost)
The Reference Price was based on the Maximum Wholesale Price (MWP) plus Value-Added-Tax (VAT) (excluded from the
maximum 10% inflationary cost)
Health facilities may have a price variation up to 10% above the DPRI to account for inflation